Intra-Biotech Alliances
This article was originally published in Start Up
Executive Summary
As pharma companies increasingly require their biotech company partners to offer more integrated technology platforms in drug discovery deals, and as more biotech companies take internally developed compounds to later stages of development, the number of intra-biotech company alliances continues to increases Advice of Counsel discusses how these deals differ from traditional alliances between biotech and pharmaceutical companies.